^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    MEDI5395

    i
    Other names: MEDI5395, MEDI 5395, MEDI-5395, recNDVGM-CSF, oncolytic newcastle disease virus therapeutic
    Associations
    News
    Trials
    Company:
    AstraZeneca
    Drug class:
    G-CSF stimulant
    Related drugs:
    Associations
    News
    Trials